Omada Health Financials - Benzinga

Omada Health Inc

OMDANASDAQ

Trade with Public

Trade with Public

$24.04

-0.33-1.35%

At close: Aug 14, 5:00 PM EST

$24.11

0.070.29%

After Hours: Aug 14, 4:18 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Omada Health Financials

Omada Health (OMDA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Omada Health Raises FY2026 Sales Guidance from $322.000M-$330.000M to $334.000M-$340.000M vs $327.789M Est

Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $322.000 million-$330.000 million to $334.000 million-$340.000 million vs $327.789 million estimate.

Benzinga Newsdesk

PRO
Omada Health Q2 EPS $0.08 Beats $(0.01) Estimate, Sales $87.835M Beat $80.190M Estimate

Omada Health (NASDAQ:OMDA) reported quarterly earnings of $0.08 per share which beat the analyst consensus estimate of $(0.01) by 900 percent. This is a 133.33 percent increase over losses of $(0.24) per share from the

Benzinga Newsdesk

PRO
Omada Health Raises FY2026 Sales Guidance from $312.000M-$322.000M to $322.000M-$330.000M vs $318.789M Est.

Omada Health (NASDAQ:OMDA) raises FY2026 sales outlook from $312.000 million-$322.000 million to $322.000 million-$330.000 million vs $318.789 million estimate.

Benzinga Newsdesk

PRO
Omada Health Q1 EPS $(0.05) Beats $(0.09) Estimate, Sales $78.048M Beat $74.036M Estimate.

Omada Health (NASDAQ:OMDA) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.09) by 44.44 percent. This is a 95.65 percent increase over losses of $(1.15) per share from the

Benzinga Newsdesk

Why Is Omada Health Stock Soaring Friday?

Omada Health (OMDA) shares surge after beating Q4 earnings and launching the GLP-1 Flex Care program for employers. Read the full report.

Vandana Singh

PRO
Omada Health Sees FY2026 Sales $312.000M-$322.000M vs $311.411M Est

Omada Health (NASDAQ:OMDA) sees FY2026 sales of $312.000 million-$322.000 million vs $311.411 million analyst estimate.

Benzinga Newsdesk